IRF5 and nonpapillary renal cell carcinoma: We had analyzed the expression of IRF5 by immunohistochemistry in ccRCC tissues and built two prediction models for overall survival (OS) and recurrence free survival (RFS), which integrated with other prognostic parameters, to refine individual risk stratification in non-metastatic ccRCC patients.